Nonsteroidal anti-inflammatory drugs enhance IgE-mediated activation of human basophils in patients with food anaphylaxis dependent on and independent of nonsteroidal anti-inflammatory drugs

Clinical and Experimental Allergy

Volumn 46, Issue 8, 2016, Pages 1111-1119

  Pascal, M ^a,b   Munoz Cano R ^a,b   Mila J ^a   Sanz, M L ^c   Diaz Perales, A ^d   Sanchez Lopez J ^a,b   Garcia Moral A ^a,b   Juan, M ^a,b   Valero, A ^a,b   Yague J ^a,b   Picado, C ^a,b   Bartra, J ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d ETSI MontesTechnical University of Madrid   (Spain)

Author keywords

anaphylaxis; basophil activation test; cofactors; food allergy; nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DEXKETOPROFEN; DICLOFENAC; DIPYRONE; FOOD ALLERGEN; IBUPROFEN; IMMUNOGLOBULIN E; LIPID TRANSFER PROTEIN; LYSINE ACETYLSALICYLATE; PEACH LIPID TRANSFER PROTEIN 3; UNCLASSIFIED DRUG; VALDECOXIB;

ADULT; ALLERGIC DISEASE; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BASOPHIL; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; FOOD ALLERGY; FOOD DEPENDENT NONSTEROID ANTIINFLAMMATORY AGENT INDUCED ANAPHYLAXIS; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MIDDLE AGED; PEACH; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; URTICARIA; YOUNG ADULT;

EID: 84979622961     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12735     Document Type: Article

References (48)

1. Cruz NV, Wilson BG, Fiocchi A, Bahna SL. Survey of physicians' approach to food allergy, Part 1: prevalence and manifestations. Ann Allergy Asthma Immunol 2007; 99:325–33.
2. Muraro A, Werfel T, Hoffmann-Sommergruber K et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 2014; 69:1008–25.
3. Panesar SS, Javad S, De Silva D et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68:1353–61.
4. Wang J, Sampson HA. Food anaphylaxis. Clin Exp Allergy 2007; 37:651–60.
5. Tejedor Alonso MA, MoroMoro MMGM. Epidemiology of anaphylaxis. Clin Exp Allergy 2015; 45:1027–39.
6. Simons FER, Ardusso LRF, Dimov V et al. World allergy organization anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013; 162:193–204.
7. Sampson HA, Aceves S, Bock SA, Joint Task Force on Practice Parameters, Bernstein D, Blessing-Moore J, Khan D, Lang D, Nic WR. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol 2014; 134:1016–25.
8. Worm M, Edenharter G, Ruëff F et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67:691–8.
9. Wölbing F, Fischer J, Köberle M, Kaesler S, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy 2013; 68:1085–92.
10. Moneret-Vautrin D-A, Latarche C. Drugs as risk factors of food anaphylaxis in adults: a case-control study. Bull Acad Natl Med 2009; 193:351–63.
11. Harada S, Horikawa T, Ashida M, Kamo T, Nishioka E, Ichihashi M. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001; 145:336–9.
12. Matsukura S, Aihara M, Sugawara M et al. Two cases of wheat-dependent anaphylaxis induced by aspirin administration but not by exercise. Clin Exp Dermatol 2010; 35:233–7.
13. Cardona V, Luengo O, Garriga T et al. Co-factor-enhanced food allergy. Allergy 2012; 67:1316–8.
14. Pascal M, Muñoz-Cano R, Reina Z et al. Lipid transfer protein syndrome: clinical pattern, cofactor effect and profile of molecular sensitization to plant-foods and pollens. Clin Exp Allergy 2012; 42:1529–39.
15. Paul E, Gall HM, Müller IMR. Dramatic augmentation of a food allergy by acetylsalicylic acid. J Allergy Clin Immunol 2000; 105:844.
16. Vidal C, Bartolomé B, González-Quintela A, Rodríguez V, Armisén M. Prawns, barnacles, and nonsteroidal anti-inflammatory drugs: effect modifiers or interaction? J Investig Allergol Clin Immunol 2007; 17:113–8.
17. Matsuo H, Morimoto K, Akaki T et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 2005; 35:461–6.
18. Shirai T, Matsui T, Uto T, Chida KNH. Nonsteroidal anti-inflammatory drugs enhance allergic reactions in a patient with wheat-induced anaphylaxis. Allergy 2003; 58:1071.
19. Romano A. Possible interaction among hypersensitivity to lipid transfer proteins, chronic urticaria, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Eur Ann Allergy Clin Immunol 2011; 43:3–4.
20. Aihara M, Miyazawa M, Osuna H et al. Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol 2002; 146:466–72.
21. Suzuki Y, Ra C. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy. J Pharmacol Sci 2009; 110:237–44.
22. Mita H, Endoh S, Kudoh M et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy 2001; 56:1061–7.
23. Picado C. Mechanisms of aspirin sensitivity. Curr Allergy Asthma Rep 2006; 6:198–202.
24. Kowalski ML, Asero R, Bavbek S et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013; 68:1219–32.
25. Sampson HA, Muñoz-Furlong A, Campbell RL et al. Second symposium on the definition and management of anaphylaxis: summary report – second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 2006; 117:391–7.
26. Ewan PW, Clark AT. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet 2001; 357:111–5.
27. Mardini IA, Fitzgerald GA. Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs. Mol Interv 2001; 1:30–8.
28. Hoffmann HJ, Santos AF, Mayorga C et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy 2015; 70:1393–405.
29. Palacín A, Gómez-Casado C, Rivas LA et al. Graph based study of allergen cross-reactivity of plant lipid transfer proteins (LTPs) using microarray in a multicenter study. PLoS One 2012; 7:e50799.
30. Santos AF, Du Toit G, Douiri A et al. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. J Allergy Clin Immunol 2015; 135:179–86.
31. Gupta RS, Lau CH, Hamilton RG, Donnell A, Newhall KK. Predicting outcomes of oral food challenges by using the allergen-specific IgE-total IgE ratio. J Allergy Clin Immunol Pract 2014; 2:300–5.
32. Blumchen K, Beder A, Beschorner J et al. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy. J Allergy Clin Immunol 2014; 134:390–8.
33. Wojnar RJ, Hearn T, Starkweather S. Augmentation of allergic histamine release from human leukocytes by nonsteroidal anti-inflammatory-analgesic agents. J Allergy Clin Immunol 1980; 66:37–45.
34. Matsuo H, Kaneko S, Tsujino Y et al. Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on serum allergen levels after wheat ingestion. J Dermatol Sci 2009; 53:241–3.
35. Matsuo H, Yokooji T, Morita H et al. Aspirin augments IgE-mediated histamine release from human peripheral basophils via Syk kinase activation. Allergol Int 2013; 62:503–11.
36. Marino O, Casolaro V, Meliota S, Tellato C, Guidi MG. Inhibition of histamine release from human FceRI+ cells by nimesulide. Agents Actions 1992; 32:C311–4.
37. Knights KM, Mangoni AA, Miners JO. Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity. Expert Rev Clin Pharmacol 2010; 3:769–76.
38. Nakamura K, Inomata NIZ. Dramatic augmentation of wheat allergy by aspirin in a dose-dependent manner. Ann Allergy Asthma Immunol 2006; 97:712–3.
39. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56:387–437.
40. Takahashi A, Nakajima K, Ikeda MSS. Pre-treatment with misoprostol prevents food-dependent exercise-induced anaphylaxis (FDEIA). Int J Dermatol 2011; 50:233–40.
41. Mortaz E, Redegeld FA, Nijkamp FP, Engels F. Dual effects of acetylsalicylic acid on mast cell degranulation, expression of cyclooxygenase-2 and release of pro-inflammatory cytokines. Biochem Pharmacol 2005; 69:1049–57.
42. Santos AF, Douiri A, Bécares N et al. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. J Allergy Clin Immunol 2014; 134:645–52.
43. Lambert GP, Boylan M, Laventure JP, Bull A, Lanspa S. Effect of aspirin and ibuprofen on GI permeability during exercise. Int J Sports Med 2007; 28:722–6.
44. Marone G, Kagey-Sobotka ALL. Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. J Immunol 1979; 123:1669–77.
45. Fernández-Rivas M, González-Mancebo E, Rodríguez-Pérez R et al. Clinically relevant peach allergy is related to peach lipid transfer protein, Pru p 3, in the Spanish population. J Allergy Clin Immunol 2003; 112:789–95.
46. Asero R, Antonicelli L, Arena A et al. Causes of food-induced anaphylaxis in italian adults: A multi-centre study. Int Arch Allergy Immunol 2009; 150:271–7.
47. Asero R. Hypersensitivity to lipid transfer protein is frequently associated with chronic urticaria. Eur Ann Allergy Clin Immunol 2011; 43:19–21.
48. Muñoz-Cano R, Pascal P, Bartra J et al. Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis. J Allergy Clin Immunol 2016; 137:137–46.